References
- Saha K , AgastiSS, KimC, LiX, RotelloVM. Gold nanoparticles in chemical and biological sensing. Chem. Rev.112, 2739–2779 (2012).
- Jokerst JV , LobovkinaT, ZareRN, GambhirSS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine6, 715–728 (2011).
- De M , MirandaOR, RanaS, RotelloVM. Size and geometry dependent protein–nanoparticle self-assembly. Chem. Commun.2157–2159 (2009).
- Nel AE , MädlerL, VelegolDet al. Understanding biophysicochemical interactions at the nano–bio interface. Nat. Mater.8, 543–557 (2009).
- Weintraub K . Biomedicine: the new gold standard. Nature495, S14–S16 (2013).
- Moyano DF , RotelloVM. Nano meets biology: structure and function at the nanoparticle interface. Langmuir27, 10376–10385 (2011).
- Alkilany AM , MurphyCJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?J. Nanopart. Res.12, 2313–2333 (2010).
- Hoffman AS . The origins and evolution of ‘controlled’ drug delivery systems. J. Control. Release132, 153–163 (2008).
- Cao Z , JiangS. Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles. Nano Today7, 404–413 (2012).
- Sekiguchi S , NiikuraK, MatsuoY, IjiroK. Hydrophilic gold nanoparticles adaptable for hydrophobic solvents. Langmuir28, 5503–5507 (2012).
- You C-C , DeM, RotelloVM. Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with α-chymotrypsin. Org. Lett.7, 5685–5688 (2005).
- Wang XY , IshidaT, KiwadaH. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J. Control. Release119, 236–244 (2007).
- Yang W , LiuS, BaiTet al. Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production. Nano Today9, 10–16 (2014).
- Lynch I , DawsonKA. Protein–nanoparticle interactions. Nano Today3, 40–47 (2008).
- Casals E , PuntesVF. Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact. Nanomedicine7, 1917–1930 (2012).
- Liu R , KayBK, JiangS, ChenS. Nanoparticle delivery: targeting and nonspecific binding. MRS Bull.34, 432–440 (2009).
- You C-C , AgastiSS, DeM, KnappMJ, RotelloVM. Modulation of the catalytic behavior of α-chymotrypsin at monolayer-protected nanoparticle surfaces. J. Am. Chem. Soc.128, 14612–14618 (2006).
- Shang W , NufferJH, Muñiz-PapandreaVAet al. Cytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. Small5, 470–476 (2009).
- You C-C , DeM, HanG, RotelloVM. Tunable inhibition and denaturation of α-chymotrypsin with amino acid-functionalized gold nanoparticles. J. Am. Chem. Soc.127, 12873–12881 (2005).
- De M , YouC-C, SrivastavaS, RotelloVM. Biomimetic interactions of proteins with functionalized nanoparticles: a thermodynamic study. J. Am. Chem. Soc.129, 10747–10753 (2007).